SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-18-031507
Filing Date
2018-10-31
Accepted
2018-10-31 21:02:03
Documents
1
Period of Report
2018-10-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 2028
  Complete submission text file 0001127602-18-031507.txt   3715
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 163 SARASOTA CIRCLE SOUTH MONTGOMERY TX 77356
Business Address
VON ESCHENBACH ANDREW C. (Reporting) CIK: 0001536529 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 181151742